CellFE
PrivateLast Round
Series A
Sep 27, 2023
Total Funding Raised
$26.8M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
CellFE is a biotechnology company that develops a microfluidic-based intracellular gene delivery platform for transporting gene-editing molecules into human cells to enhance cell therapies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CellFE Comparables
Compare CellFE with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Indee Labs | 87% | |
| Portal Biotechnologies | 86% | |
| Avectas | 85% |
CellFE Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Sep 27, 2023 | ||||
| Seed | Mar 31, 2020 | ||||
| Grant | Aug 27, 2019 |
Key People
Founding team and executive leadership
CellFE Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| Cota Capital | Series A, Seed |
| Dynamk Capital | Series A, Seed |
| Khosla Ventures | Series A |
| Embark Ventures | Seed, Series A |
| M Ventures | Series A |
| Elm Street Ventures | Seed, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 26, 2026
Monthly visitors increased 115% MoM, reaching 1.9K.
- Apr 30, 2025
Collaborating with Tcelltech GmbH to advance cell therapy development.
CellFE Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about CellFE's valuation, stock price, and market status.
Is CellFE a public or private company?
CellFE is a private company.
What is the current stock price of CellFE?
CellFE is a private company with no public stock price. No recent secondary market data is available.
How much is CellFE worth (valuation)?
Valuation information for CellFE is not publicly available.
Can I buy CellFE stock?
CellFE shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was CellFE's last funding round?
CellFE's most recent funding round was Series A on September 27, 2023.
Who are the main investors in CellFE?
Key investors in CellFE include Cota Capital, Dynamk Capital, M Ventures.
Will CellFE IPO soon?
No public IPO plans have been announced for CellFE.
How can I track CellFE secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CellFE's secondary market activity and sign up for updates.